Assessment of immunological reaction to mRNA SARS CoV-2 vaccine after administration of Tixagevimab/Cilgavimab, using B cell receptor repertoire analysis

What issues will remain after Covid-19 is downgraded to Class 5?

Vaccine developed for human herpesvirus 6B (HHV-6B)

New insights on the virus that causes shingles